Blue Bird (BLBD): Director bought ~$16K
Daniel Mark Thau, Director at Blue Bird, bought ~$16K of Blue Bird shares.
- ~$16K
- Approx. value · 400 sh @ $39.17
- 5,699
- Holds after · shares reported
- Traded
- May 28, 2025
- Filed
- May 29, 2025
What stands out in this filing
- The purchase added 7.5% to the shares this insider held before it; the filing reports 5,699 shares afterwards.
- 400 shares at an average of $39.17 each, as reported on the form.
- The first open-market purchase by this insider in 3 months.
Calculated by OQRO from this filing and the public records it holds. Facts about the record, not a reason for the trade and not a signal.
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Apr 7, 2025CongressDisclosed sale of BLBD — reported range $1,001 - $15,000
- Apr 21, 2025FDA · NHTSA campaign 25V249000Vehicle recall of 162 units: electrical system, software
- May 6, 2025FDA · NHTSA campaign 25V289000Vehicle recall of 34 units: seats, critical fasteners
- May 28, 2025 · this disclosureInsiderDirector purchased ~$16K of BLBD shares in the open market
What came next
- Jun 10, 2025InsiderDirector sold ~$364K of BLBD shares in the open market
- Jun 11, 2025Insider · 1 personInsiders: 2 sales (~$554K)
- Jun 12, 2025InsiderDirector sold ~$616K of BLBD shares in the open market
- Jul 8, 2025InsiderCFO sold ~$452K of BLBD shares in the open market
- Aug 7, 2025InsiderCFO sold ~$532K of BLBD shares in the open market
- Aug 8, 2025Insider · 2 peopleInsiders: 2 sales (~$1.8M)
- Aug 12, 2025InsiderOfficer sold ~$490K of BLBD shares in the open market
- Aug 13, 2025InsiderDirector sold ~$888K of BLBD shares in the open market
- Aug 15, 2025InsiderDirector sold ~$1.21M of BLBD shares in the open market
- Aug 18, 2025InsiderDirector sold ~$1.23M of BLBD shares in the open market
- Aug 28, 2025InsiderDirector sold ~$767K of BLBD shares in the open market
- Sep 2, 2025InsiderCFO sold ~$385K of BLBD shares in the open market
- Sep 12, 2025InsiderDirector sold ~$788K of BLBD shares in the open market
- Sep 23, 2025FDA · NHTSA campaign 25V635000Vehicle recall of 150 units: parking brake, electrical, control module
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Blue Bird
For Blue Bird, OQRO holds 2 fund holdings reports (13F) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its BLBD page.
Other recent filings by Daniel Mark Thau, Director
The full history of Daniel Mark Thau, Director is on the profile page.
How this filing works
Explore the data
Common questions
Which Blue Bird (BLBD) insider traded, and how much?
Daniel Mark Thau, Director at Blue Bird, bought ~$16K of Blue Bird shares. 400 shares at $39.17, open market.
When did it happen, and when was it made public?
Traded: May 28, 2025. Filed: May 29, 2025. That is 1 day between the two dates.
What stands out in this filing?
The purchase added 7.5% to the shares this insider held before it; the filing reports 5,699 shares afterwards. 400 shares at an average of $39.17 each, as reported on the form. The first open-market purchase by this insider in 3 months.
Is the dollar amount exact?
It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.
Where does this information come from?
From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.
What else has been disclosed about Blue Bird recently?
For Blue Bird, OQRO holds 2 fund holdings reports (13F) dated in the last 90 days. They are listed on the BLBD page.
Does this mean BLBD stock is a buy or a sell?
No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.
Is OQRO free?
Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.
Other disclosures at Blue Bird
- SEC Schedule 13GNov 16, 2026
- SEC Schedule 13GOct 20, 2026
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRAug 12, 2026
- SEC Form 13F-HRMay 15, 2026
Everything OQRO holds on this company is on its BLBD page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
